Don't rush to replace the copper peptides with another active
In preclinical and in vitro studies, the three components are being researched in relation to tissue repair and skin-related processes: BPC-157 in connection with the formation of new blood vessels and tissue regeneration, TB-500 in connection with cell migration, and GHK-Cu in connection with collagen formation and skin structure
2):ii1326
BPC-157 Dosing for Tendon Repair Common Protocols Conservative approach (8-week cycle): Dose: 250-500mcg per day Route: Subcutaneous injection Frequency: Daily Duration: 8-12 weeks Break: 4 weeks between cycles Aggressive approach (ongoing): Dose: 500mcg daily for 6 weeks Then: 250mcg 2-3x weekly maintenance Route: Subcutaneous or intranasal Duration: Continuous until injury resolved Localized injection (advanced): Direct injection into injured tendon (medical supervision required) Dose: 250-500mcg Frequency: 1-2x weekly Duration: 4-8 weeks Results: May be superior, but requires qualified practitioner Administration Routes Subcutaneous (most common): 250-500mcg in 0.5mL water, injected daily Painless, stable delivery Consistent blood levels Intranasal: 250mcg sprayed into nostrils daily Non-invasive, good absorption Less evidence but growing anecdotal support Oral: Limited effectiveness (degraded by stomach acid) Not recommended for serious injury recovery Real-World Results: Athlete Case Studies Case 1: Chronic Patellar Tendinopathy (Runner) Situation : 3 years of patellar tendon pain, limiting running to 3 miles max Protocol : BPC-157: 500mcg daily for 8 weeks Eccentric loading exercises 3x weekly Return to training protocol structured over 12 weeks Result : After 4 months, pain-free running at pre-injury distances
This product is not classified as a drug, food, or cosmetic and must not be misbranded, misused, or mislabeled as such
